The U.S. Food and Drug Administration (FDA) on Wednesday approved Omeros Corporation (NASDAQ: OMER) Yartemlea ...

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...

Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...

With heavy rain continuing to fall across the Townsville region, the Ross River Dam is likely to hit 100 percent in the next 12 to 24 hours ...

MND patients in the UK denied access to lifesaving drug tofersen, despite Biogen supplying it free, due to NHS covering ...

Inherited retinal degenerations (IRDs) were found by Mass Eye and Ear researchers to occur in only 28% of people who carry IRD genetic ...

Developer Sloclap is currently testing a brand-new game mode for Rematch called Duel. Duel is set to be a 1v1 mode "built around dribbling, precision, and goal blockers" that will provide players with ...

In year one of AirMail Focus, the sharpest minds in business aviation dissect talent, safety, law, markets and maintenance ...

EAP's exports now face higher trade restrictions, elevated policy uncertainty, and slowing global growth. And its workers must cope with the growing use of robots, AI, and digital platforms. Download ...

Deals If you're looking for a Nintendo Switch 2 controller on a budget, this pick has dropped to its lowest-ever price. Feature 2025 has been the year of the TMR controller, so I'm counting down the ...